Omics for Personalized Medicine

Omics for Personalized Medicine

4.11 - 1251 ratings - Source

a€œOmics for Personalized Medicinea€ will give to its prospective readers the insight of both the current developments and the future potential of personalized medicine. The book brings into light how the pharmacogenomics and omics technologies are bringing a revolution in transforming the medicine and the health care sector for the better. Students of biomedical research and medicine along with medical professionals will benefit tremendously from the book by gaining from the diverse fields of knowledge of new age personalized medicine presented in the highly detailed chapters of the book. The book chapters are divided into two sections for convenient reading with the first section covering the general aspects of pharmaocogenomic technology that includes latest research and development in omics technologies. The first section also highlights the role of omics in modern clinical trials and even discusses the ethical consideration in pharmocogenomics. The second section is focusing on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even explores the role of pharmacogenomics in cell therapy and transplantation technology. Thirty-four chapters of the book cover several aspects of pharmacogenomics and personalized medicine and have taken into consideration the varied interest of the readers from different fields of biomedical research and medicine. Advent of pharmacogenomics is the future of modern medicine, which has resulted from culmination of decades of research and now is showing the way forward. The book is an honest endeavour of researchers from all over the world to disseminate the latest knowledge and knowhow in personalized medicine to the community health researchers in particular and the educated public in general.Vance JM, Tekin D (2011) Genomic medicine and neurology. ... Lubec G (2001) Decreased brain levels of 2a#39;, 3a#39;-cyclic nucleotide-3a#39;phosphodiesterase in Down syndrome and Alzheimera#39;s disease. ... Proc Natl Acad Sci USA 94:8208a€“8213 Xia W, Ray WJ, Ostaszewski BL, Rahmati T, Kimberly WT, Wolfe MS, Zhand J, Goate AM, Selkoe DJ (2000) ... (2010) CNS-resident glial progenitor/ stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination.

Title:Omics for Personalized Medicine
Author:Debmalya Barh, Dipali Dhawan, Nirmal Kumar Ganguly
Publisher:Springer Science & Business Media - 2013-10-14


You Must CONTINUE and create a free account to access unlimited downloads & streaming